SmartSkin Technologies ads

We’ve got big news to share! SmartSkin Technologies and SCHOTT Pharma have launched the SmartLine Program to help pharmaceutical manufacturers and CDMOs prevent glass container damage on the line. If you’ve ever dealt with breakage, you know how it goes. A vial cracks, and your team has to work out why. Was it the glass? The equipment? Something three stations back? The damage is visible. Where it began often isn’t. Without that information, teams can spend hours investigating, only to see the same issue return. SmartLine brings together two kinds of expertise to help teams find answers and make improvements that last, here's how: 1. Our Digital Container Twins measure where and how much force your containers experience on the line. 2. SCHOTT Pharma tests the glass in its ISO 17025 accredited lab to determine which forces cause damage. 3. Together, those findings help your team identify the source of damage and establish setup standards you can reuse at every changeover. This program was inspired by work with a global pharmaceutical manufacturer that reduced vial chip and crack losses by 70%. We’re proud to build on that experience with SCHOTT Pharma and make this support available to more teams. If glass breakage, container damage or seal issues are costing your team time, see what SmartLine could mean for your line: https://lnkd.in/eY8ZxN89 #PharmaManufacturing #FillFinish #GlassPackaging

What happens to a container once it reaches the manufacturing line? That question took on new meaning for Michieva Flores, SmartSkin Account Manager, for Pharma North America, when she first saw Digital Container Twins in action. Coming from pre-clinical research, the technology gave her a view into a part of the pharmaceutical process she had never considered: the forces containers experience during manufacturing. In this video, Michieva shares why her first reaction was simply, “Wow.” She’ll be at PDA/FDA in Washington, D.C. Stop by Booth #300 on September 14 or 15 to say hi and ask for a demo, you may find yourself saying “Wow” too. PDA - Parenteral Drug Association #PDAFDA Schedule a demo: https://lnkd.in/gDheDcAb

𝗠𝗼𝘀𝘁 𝘀𝗲𝗮𝗺 𝗳𝗮𝗶𝗹𝘂𝗿𝗲𝘀 𝗮𝗿𝗲 𝗻𝗼𝘁 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝗲𝗱 𝗼𝗻 𝘁𝗵𝗲 𝗹𝗶𝗻𝗲. Weak seams can survive filling. They can survive pasteurization. They can survive palletization. The defect is not always immediate. It often appears later: During transport In the warehouse On the retail shelf By that point, the operational cost is multiplied. What makes this dangerous is not a dramatic failure event. It is reduced stability margin that goes unnoticed during production. Inspection confirms integrity at the moment of test. It does not measure how much resilience remains in the system. When margin is low, distribution stress becomes the trigger. High-performing operations do not simply prevent defects. They prevent instability from leaving the plant. Risk does not increase in the warehouse. It was already there.

Changeovers shouldn’t rely on trial and error. SmartSkin showed one beverage plant that its seamer was applying far too little force despite appearing in spec and turned verification into a repeatable part of every changeover.

The seamer looked in spec. Actual vertical load was nearly half the minimum target. SmartSkin revealed the gap, helped operators correct the setup, and eliminated seam leaks after changeover.

A weak seam may pass line checks and later fail in the warehouse. See how SmartSkin uncovered a hidden low-force condition, eliminated seam leaks, and made changeover verification repeatable.